BACKGROUND AND OBJECTIVES: Peritoneal interstitial fibrosis and hyalinizing vasculopathy were induced by peritoneal dialysis and other associated conditions (e.g., uremia). A quantitative method for peritoneal biopsy evaluation is required to investigate possible causative factors and severity of the peritoneal dialysis-related peritoneal alterations. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Peritoneal biopsy specimens from 173 uremic (before peritoneal dialysis) and 80 peritoneal dialysis patients with or without impaired ultrafiltration capacity were evaluated by average peritoneal thickness of submesothelial compact zone measured at five randomly selected points of peritoneum and by lumen/vessel diameter ratio at postcapillary venule. RESULTS: The average peritoneal thickness was increased in uremic patients and progressively thickened as the duration of peritoneal dialysis prolonged. The lumen/vessel diameter ratio was lower in uremia than normal and progressively decreased as the duration of peritoneal dialysis prolonged. In pre-peritoneal dialysis peritoneum, patients with diabetes showed significant decrease in lumen/vessel diameter ratio compared with patients without diabetes. The average peritoneal thickness was significantly higher in patients with impaired ultrafiltration capacity than in patients with maintained ultrafiltration capacity; however, no significant difference was observed in the postcapillary venule thickness and lumen/vessel diameter ratio between the two groups. CONCLUSIONS: The average peritoneal thickness and lumen/vessel diameter ratio were useful morphologic parameters to quantify the severity of the peritoneal alterations in uremic and peritoneal dialysis patients. Uremia and diabetes had an impact on the pathogenesis of peritoneal sclerosis in pre-peritoneal dialysis peritoneum. Peritoneal dialysis treatment itself had a much stronger impact on the progression of peritoneal sclerosis.
BACKGROUND AND OBJECTIVES: Peritoneal interstitial fibrosis and hyalinizing vasculopathy were induced by peritoneal dialysis and other associated conditions (e.g., uremia). A quantitative method for peritoneal biopsy evaluation is required to investigate possible causative factors and severity of the peritoneal dialysis-related peritoneal alterations. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Peritoneal biopsy specimens from 173 uremic (before peritoneal dialysis) and 80 peritoneal dialysis patients with or without impaired ultrafiltration capacity were evaluated by average peritoneal thickness of submesothelial compact zone measured at five randomly selected points of peritoneum and by lumen/vessel diameter ratio at postcapillary venule. RESULTS: The average peritoneal thickness was increased in uremic patients and progressively thickened as the duration of peritoneal dialysis prolonged. The lumen/vessel diameter ratio was lower in uremia than normal and progressively decreased as the duration of peritoneal dialysis prolonged. In pre-peritoneal dialysis peritoneum, patients with diabetes showed significant decrease in lumen/vessel diameter ratio compared with patients without diabetes. The average peritoneal thickness was significantly higher in patients with impaired ultrafiltration capacity than in patients with maintained ultrafiltration capacity; however, no significant difference was observed in the postcapillary venule thickness and lumen/vessel diameter ratio between the two groups. CONCLUSIONS: The average peritoneal thickness and lumen/vessel diameter ratio were useful morphologic parameters to quantify the severity of the peritoneal alterations in uremic and peritoneal dialysis patients. Uremia and diabetes had an impact on the pathogenesis of peritoneal sclerosis in pre-peritoneal dialysis peritoneum. Peritoneal dialysis treatment itself had a much stronger impact on the progression of peritoneal sclerosis.
Authors: John D Williams; Kathrine J Craig; Nicholas Topley; Christopher Von Ruhland; Maureen Fallon; Geoffrey R Newman; Ruth K Mackenzie; Geraint T Williams Journal: J Am Soc Nephrol Date: 2002-02 Impact factor: 10.121
Authors: T Miyata; K Horie; Y Ueda; Y Fujita; Y Izuhara; H Hirano; K Uchida; A Saito; C van Ypersele de Strihou; K Kurokawa Journal: Kidney Int Date: 2000-07 Impact factor: 10.612
Authors: R Inagi; T Miyata; T Yamamoto; D Suzuki; K Urakami; A Saito; C van Ypersele de Strihou; K Kurokawa Journal: FEBS Lett Date: 1999-12-17 Impact factor: 4.124
Authors: N Di Paolo; G Sacchi; M De Mia; E Gaggiotti; L Capotondo; P Rossi; M Bernini; A M Pucci; L Ibba; P Sabatelli Journal: Nephron Date: 1986 Impact factor: 2.847
Authors: K Yamada; Y Miyahara; K Hamaguchi; M Nakayama; H Nakano; O Nozaki; Y Miura; S Suzuki; H Tuchida; N Mimura Journal: Clin Nephrol Date: 1994-12 Impact factor: 0.975
Authors: Lars P Kihm; Sandra Müller-Krebs; Julia Klein; Gregory Ehrlich; Laura Mertes; Marie-Luise Gross; Antonysunil Adaikalakoteswari; Paul J Thornalley; Hans-Peter Hammes; Peter P Nawroth; Martin Zeier; Vedat Schwenger Journal: J Am Soc Nephrol Date: 2011-04-21 Impact factor: 10.121
Authors: M José Fernández-Reyes; M Auxiliadora Bajo; Gloria Del Peso; Marta Ossorio; Raquel Díaz; Beatriz Carretero; Rafael Selgas Journal: Perit Dial Int Date: 2012-04-02 Impact factor: 1.756
Authors: Johann Morelle; Amadou Sow; Nicolas Hautem; Caroline Bouzin; Ralph Crott; Olivier Devuyst; Eric Goffin Journal: J Am Soc Nephrol Date: 2015-01-30 Impact factor: 10.121
Authors: Antonio Fernández-Perpén; María Luisa Pérez-Lozano; María-Auxiliadora Bajo; Patricia Albar-Vizcaino; Pilar Sandoval Correa; Gloria del Peso; María-José Castro; Abelardo Aguilera; Marta Ossorio; Mirjam E Peter; Jutta Passlick-Deetjen; Luiz S Aroeira; Rafael Selgas; Manuel López-Cabrera; J Antonio Sánchez-Tomero Journal: Perit Dial Int Date: 2012-01-03 Impact factor: 1.756